AHC
BSX icon

Adell Harriman & Carpenter’s Boston Scientific BSX Stock Holding History

Adell Harriman & Carpenter’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Sell
30,509
-24,646
-45% -$1.97M 0.12% 90
2025
Q4 		$5.26M Sell
55,155
-1,331
-2% -$130K 0.31% 59
2025
Q3 		$5.51M Buy
56,486
+11,007
+24% +$1.14M 0.33% 59
2025
Q2 		$4.88M Buy
45,479
+19,735
+77% +$2M 0.32% 62
2025
Q1 		$2.6M Buy
+25,744
New +$2.59M 0.2% 76

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Adell Harriman & Carpenter's BSX Position: Q1 2026 in Review

Adell Harriman & Carpenter reduced its Boston Scientific (BSX) stake by 45% in Q1 2026, selling an estimated $1.97M and leaving 30,509 shares worth $1.91M. The position accounts for 0.12% of the portfolio, ranked #90.

Adell Harriman & Carpenter first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.51M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Adell Harriman & Carpenter held 30,509 shares of Boston Scientific worth $1.91M as of Q1 2026.
  • Adell Harriman & Carpenter sold 24,646 Boston Scientific shares in Q1 2026, an estimated $1.97M.
  • Boston Scientific made up 0.12% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #90 holding.
  • Adell Harriman & Carpenter first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Adell Harriman & Carpenter's Boston Scientific position peaked at $5.51M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.